Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
52.1M
-
Shares change
-
-986K
-
Total reported value, excl. options
-
$692M
-
Value change
-
-$17.1M
-
Put/Call ratio
-
3.79
-
Number of buys
-
100
-
Number of sells
-
-60
-
Price
-
$13.28
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2019
185 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2019.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
of 58.9M outstanding shares and own 88.53% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.08M shares), Palo Alto Investors LP (4.58M shares), VANGUARD GROUP INC (4.31M shares), ARMISTICE CAPITAL, LLC (3.55M shares), RENAISSANCE TECHNOLOGIES LLC (3.21M shares), STATE STREET CORP (2.87M shares), MACQUARIE GROUP LTD (2.79M shares), Invesco Ltd. (1.44M shares), Nuveen Asset Management, LLC (1.16M shares), and DIMENSIONAL FUND ADVISORS LP (1.12M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.